MedPath

Telerehabilitation After Coronavirus

Not Applicable
Completed
Conditions
COVID
Registration Number
NCT04473898
Lead Sponsor
KTO Karatay University
Brief Summary

The aim of the study is to investigate the effects of telerehabilitation program on COVID-19 symptoms, quality of life, level of depression, perception of dyspnea, sleep, fatigue, kinesiophobia and patient satisfaction in individuals diagnosed with COVID-19.

Detailed Description

Because of the risk of infection, telerehabilitation applications are recommended for patients with COVID-19. There are no studies in the literature evaluating the effectiveness of telerehabilitation program after COVID-19. In particular, the importance of the first eight weeks after the disease was emphasized.

It is thought that the telerehabilitation program will improve the functional capacities and quality of life of patients in order to adapt to the daily life after the infection more easily, to cope with the symptoms brought about by the disease more easily and to prevent the respiratory distress, intensive care stay and inactivity due to muscle weakness.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • volunteering to participate in the study
  • at least once diagnosed with COVID-19,
  • has a cognitive level that can adapt to online exercises,
  • having a physical condition suitable for exercises
  • staying in hospital due to covid-19
Exclusion Criteria
  • refuse to participate in the study
  • having neurological, cardiac, respiratory disease that prevents exercise

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Health Related Quality of Life6 weeks later

It will be evaluated by SF-36

Sleep Quality6 weeks later

It will be evaluated by pittsburgh sleep quality index

Dyspnoea6 weeks later

It will be evaluated by the Modified Medical Research Council (mMRC). It will be evaluated by the Modified Medical Research Council (mMRC). It consists of 5 items between 0 and 4. The increase in the score indicates the severity of dyspnea.

Anxiety and Depression6 weeks later

It will be evaluated by the Hospital Anxiety and Depression Scale (HADS). The questionnaire comprises seven questions for anxiety and seven questions for depression, and takes 2-5min to complete. Although the anxiety and depression questions are interspersed within the questionnaire, it is vital that these are scored separately. Cut-off scores are available for quantification, for example a score of 8 or more for anxiety. The increase in the score indicates the severity of anxiety and depression.

Secondary Outcome Measures
NameTimeMethod
Kinesiophobia6 weeks later

It will be evaluated by Kinesiophobia Causes Scale. The questionnaire consist of 20 closed questions, assessed in a range from 0 to 100 - a higher score indicating a higher fear of movement

Patient Satisfaction6 weeks later

It will be evaluated by patient satisfaction scale. Likert scale questionnaire proposed seven dimensions of patient satisfaction directed toward their doctors. These are general satisfaction, technical quality, interpersonal manner, communication, financial aspects, time spent with doctor, and accessibility and convenience. Increased score indicates decreased satisfaction. The minimum score is 18, the maximum score is 90.

Fatigue6 weeks later

It will be evaluated by Fatigue Severity Scale. A self-report scale of nine items about fatigue, its severity and how it affects certain activities. Answers are scored on a seven point scale where 1 = strongly disagree and 7 = strongly agree. This means the minimum score possible is nine and the highest is 63.

Trial Locations

Locations (1)

KTO Karatay University

🇹🇷

Konya, Karatay, Turkey

KTO Karatay University
🇹🇷Konya, Karatay, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.